Warby Parker (WRBY) Non Operating Income (2020 - 2026)
Warby Parker's (WRBY) quarterly Non Operating Income came in at $2.3 million in Q1 2026, down 5.05% YoY from $2.5 million in Q1 2025, and up 32.37% on a QoQ basis from $1.8 million in Q4 2025.
Warby Parker (WRBY) Non Operating Income (2020 - 2026) Analysis & Trends
Warby Parker (WRBY) has 7 years of Non Operating Income data on file, last reported at $2.3 million in Q1 2026.
- Quarterly Non Operating Income fell 5.05% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.3 million (down 21.35% YoY) and the FY2025 annual result came in at $8.4 million, down 20.93% from the prior year.
- Non Operating Income advanced to $2.3 million in Q1 2026, from $1.8 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $2.8 million in Q3 2024 to a low of -$183000.0 in Q3 2022.
- A 5-year average of $1.9 million and a median of $2.3 million in 2023 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2023 — Non Operating Income surged 6102.63% — and 2025, when it slumped 33.09%.
- Tracing WRBY's Non Operating Income over 5 years: stood at $1.4 million in 2022, then surged by 74.89% to $2.4 million in 2023, then increased by 8.9% to $2.6 million in 2024, then tumbled by 33.09% to $1.8 million in 2025, then jumped by 32.37% to $2.3 million in 2026.
- The last three Non Operating Income figures came in at $2.3 million (Q1 2026), $1.8 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 82.70 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -160.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -12.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.50 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Warby Parker | 3.41 Bn | 3.12 Bn | 136.46 Mn | 2.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.08 Mn |
| Mar 31, 2026 | 2.33 Mn |
| Dec 31, 2025 | 1.76 Mn |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 1.98 Mn |
| Mar 31, 2025 | 2.46 Mn |
| Dec 31, 2024 | 2.63 Mn |
| Sep 30, 2024 | 2.84 Mn |
| Jun 30, 2024 | 2.57 Mn |
| Mar 31, 2024 | 2.56 Mn |
| Dec 31, 2023 | 2.42 Mn |
| Sep 30, 2023 | 2.66 Mn |
| Jun 30, 2023 | 2.28 Mn |
| Mar 31, 2023 | 1.88 Mn |
| Dec 31, 2022 | 1.38 Mn |
| Sep 30, 2022 | -183,000.00 |
| Jun 30, 2022 | -38,000.00 |
| Mar 31, 2022 | 146,000.00 |
| Dec 31, 2021 | 105,000.00 |
| Sep 30, 2021 | -146,000.00 |